Over the past two decades, much progress has been made in the care of extremely premature infants. Nonetheless, the incidence of prematurity has actually increased and in the face of increasing survival, clinicians are still faced with the challenge of caring for extremely premature infants and their associated morbidities.
Perinatal medicine is advancing toward an evidence-based approach, with a movement toward 'best practice' in defining the standard of care. Clinicians, however, are faced with the lack of randomized clinical trials for many routinely practiced interventions. This dilemma exists despite the significant scientific, clinical and technological advances in neonatal-perinatal medicine.
In 2004, the steering committee for Evidence vs Experience in Neonatal Practices (Rangasamy Ramanathan, MD, Kris Sekar, MD, Istvan Seri, MD, PhD, and I) conceived the concept of a conference that would embrace routine practice issues. Where evidence is lacking, experience and discussion with a scholarly group will enhance our understanding in providing care for this very vulnerable population.
For our second annual conference (San Diego, June 2005), the steering committee identified several areas of focus: hemodynamics, nutrition, ventilation management, bronchopulmonary dysplasia, surfactant therapy, and retinopathy of prematurity. We invited experts renowned for their original research and experience, from the United States and Europe to participate. Within the hemodynamics section, Dr Sekar reviewed present experience with nitric oxide in pulmonary hypertension, Dr Clyman presented present research on patent ductus arteriosus, and Dr Seri examined the management of hypotension and low systemic blood flow. In reviewing nutrition aspects of care, Dr Adamkin discussed postdischarge nutritional therapy, whereas my presentation focused on fluid and electrolyte imbalances. For the ventilation therapy session, Dr Bancalari examined the evidence surrounding the use of continuous positive airway pressure (CPAP) and Dr Soll led us through an insightful meta-analysis on the use of high-frequency ventilation. Dr Ramanathan shared with us present perspectives on surfactant therapy specific to neonatal respiratory distress syndrome. Professor Saugstad from Oslo, Norway gave an outstanding overview on retinopathy of prematurity as our keynote presentation. I added to the program a unique presentation examining palliative care issues in the fetus and neonate. Finally, closing the conference was Professor Speer's presentation on bronchopulmonary dysplasia.
The faculty outlined the evidence, reviewed the experience, and examined the challenges in providing care for premature infants. Coupled with these presentations were lively discussions between the audience and the faculty, spurred on by faculty pre and post questions, which utilized audience-response technology to capture feedback from our audience.
This supplement represents the proceedings of this conference. It is composed of summaries from each of the presentations and the discussion sessions during this conference. As we move toward better defining 'best practices' in neonatal medicine, an exchange like this will only further enhance our understanding and knowledge in providing the very best care for these babies.
As the program chair for this second annual conference, I find it important to recognize all those involved in making this conference and proceedings possible. My appreciation is extended to my steering committee colleagues and guest editors (Drs Ramanathan, Sekar, and Seri) who were invaluable and stimulating collaborators during the organization of this meeting. I also specially thank the Annenberg Center for Health Sciences, which provided the organizational support for the conference. Furthermore, I recognize the support of Akita Biomedical Consulting and John M. York, PharmD, in assisting the steering committee and faculty in preparing this conference and proceedings. Sheilyn Huang, PharmD and Namita Kothary, PharmD of Robert Wood Johnson University Hospital provided significant support in helping our faculty with their submissions to the Journal of Perinatology. I am very grateful to our world-renowned faculty who took time to present their work and participate in all the discussions. I acknowledge DEY, LP for providing an unrestricted educational grant, which made this conference possible. Finally, I thank Gil Martin, MD (Supplements Editor), Joyce-Rachael John (Executive Editor) and the staff of the Journal of Perinatology and the Nature Publishing Group for publishing these proceedings.
The audience feedback of this conference and format was very positive and plans are under way for the third conference to be held in Boston in June 2006. We hope you will be able to join us again.
